Dimethyl Fumarate
-
Product Name:
Dimethyl Fumarate
-
Molecular Formula:
C6H8O4
-
Molecular Weight:
144.12 g/mol
-
CAS No.:
624-49-7
-
HSN Code:
29171990
-
CID Code:
637568
-
Shelf Life:
3 years - 20°C powder
-
ATC Code (WHO)
L04AX07
-
DrugBank ID
DB08908
-
ChemSpider ID
553171
-
UNII No.
FO2303MNI2
- USP
- IUPAC Names
- Synonyms
USP of Dimethyl Fumarate
Dimethyl Fumarate is used to treat relapses of multiple sclerosis, including relapsing-remitting disease, clinically isolated syndrome, and active secondary progressive disease. This medicine can decrease the number of relapses of multiple sclerosis.
IUPAC Names of Dimethyl Fumarate
dimethyl (E)-but-2-enedioate
Synonyms of Dimethyl Fumarate
- Dimethyl fumarate
- (E)-Dimethyl fumarate
- Dimethylfumarate
- Methyl fumarate
- Fumaric acid, dimethyl ester
- Dimethyl (E)-but-2-enedioate
- Fumaric acid dimethyl ester
- Boletic acid dimethyl ester
- Dimethyl trans-ethylenedicarboxylate
- trans-Butenedioic acid dimethyl ester
- Allomaleic acid dimethyl ester
- dimethyl (2E)-but-2-enedioate
- trans-1,2-Ethylenedicarboxylic acid dimethyl ester
- 2-Butenedioic acid (E)-, dimethyl ester
- Dimethylester kyseliny fumarove
- (E)-but-2-enedioic acid dimethyl ester
- dimethyl-fumarate
- Dimethyl fumarate
- 2-Butenedioic acid (2E)-, dimethyl ester
- UNII-FO2303MNI2
- 1,2-bis(methoxycarbonyl)-trans-ethylene
- Dimethyl 2-butenedioate
- Ethylene, 1,2-bis(methoxycarbonyl)-, trans-
- Fumaric acid-dimethyl ester
- 2-butenedioic Acid, Dimethyl Ester, (E)-
- Dimethyl (2e)-2-butenedioate
- 2-butenedioic acid, (2E)-, dimethyl ester
- dimethyl (~{E})-but-2-enedioate
- But-2-enedioic acid, dimethyl ester
- 2-Butenedioic acid, dimethyl ester
- 2-Butenedioic acid (2E)-, 1,4-dimethyl ester
- Ethylene,2-bis(methoxycarbonyl)-, trans-
- 1,4-dimethyl but-2-enedioate
- dimethyl trans-butenedioate
- Dimethyl ester(E)-2-Butenedioic acid
- (E)-CH3OC(O)CH=CHC(O)OCH3
- 1,4-dimethyl (2E)-but-2-enedioate
- Dimethyl ester(2E)-2-Butenedioic acid
If you are interested on Dimethyl Fumarate, then
Description of Dimethyl Fumarate
Multiple sclerosis affects the central nervous system. It damages nerves that send messages from the brain to other parts of human body. Dimethyl Fumarate helps to decrease the number of multiple sclerosis relapses in individuals with relapsing or remitting forms of the disease. It may not provide a cure but decrease the number of relapses.
Application of Dimethyl Fumarate
- Multiple Sclerosis (MS) Treatment: Primarily used for the treatment of relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. DMF helps in reducing the frequency and severity of relapses and slowing the progression of disability.
- Psoriasis Management: Effective in the treatment of moderate to severe plaque psoriasis. DMF helps in controlling the symptoms and progression of this chronic skin condition.
- Anti-Inflammatory Properties: Exhibits anti-inflammatory effects, which are beneficial in treating conditions like MS and psoriasis.
- Neuroprotective Effects: Investigated for its neuroprotective properties, potentially beneficial in neurodegenerative diseases beyond MS.
- Oxidative Stress Reduction: DMF is known to reduce oxidative stress, which is a factor in the pathology of several chronic diseases.
- Immunomodulatory Effects: Acts as an immunomodulator, altering the immune response, which is key in its effectiveness in autoimmune conditions like MS.
- Research in Other Autoimmune Diseases: Being studied for potential use in other autoimmune diseases due to its immunomodulatory and anti-inflammatory properties.
- Potential in Fibrotic Diseases: Early research suggests possible applications in treating fibrotic diseases due to its effects on certain pathways involved in fibrosis.
- Antioxidant Properties: DMF has antioxidant properties, which contribute to its therapeutic effects in inflammatory and autoimmune diseases.
If you are interested on Dimethyl Fumarate, then
Related Products
